STANDARD BIOTOOLS INC. — Director's Dealing 2022

Nov 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-11-21

Reporting Person: JOG VIKRAM (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-21	Common Stock	M	3131	—	Acquired	169957	Direct
2022-11-21	Common Stock	M	2391	—	Acquired	172348	Direct
2022-11-21	Common Stock	M	2237	—	Acquired	174585	Direct
2022-11-21	Common Stock	F	2681	$1.43	Disposed	171904	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-21	Restricted Stock Units	$	M	3131	Disposed		Common Stock (3131.0)	Direct
2022-11-21	Restricted Stock Units	$	M	2391	Disposed		Common Stock (2391.0)	Direct
2022-11-21	Restricted Stock Units	$	M	2237	Disposed		Common Stock (2237.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	52061	Indirect

Footnotes

F1: Shares held indirectly by the Vikram and Pratima Jog Family Trust U/A dated June 23, 2009.

F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F3: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.

F4: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F5: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.